We present a new method, TrackSig, to estimate the evolutionary trajectories of signatures of different somatic mutational processes from DNA sequencing data from a single, bulk tumour sample. TrackSig uses probability distributions over mutation types, called mutational signatures, to represent different mutational processes and detects the changes in the signature activity using an optimal segmentation algorithm that groups somatic mutations based on their estimated cancer cellular fraction (CCF) and their mutation type (e.g. CAG->CTG). We use two different simulation frameworks to assess both TrackSig's reconstruction accuracy and its robustness to violations of its assumptions, as well as to compare it to a baseline approach. We find 2-4% median error in reconstructing the signature activities on simulations with varying difficulty with one to three subclones at an average depth of 30x. The size and the direction of the activity change is consistent in 83% and 95% of cases respectively. There were an average of 0.02 missed and 0.12 false positive subclones per sample. In our simulations, grouping mutations by mutation type (TrackSig), rather than by clustering CCF (baseline strategy), performs better at estimating signature activities and at identifying subclonal populations in the complex scenarios like branching, CNA gain, violation of infinite site assumption, and the inclusion of neutrally evolving mutations. TrackSig is open source software, freely available at https://github.com/morrislab/TrackSig. 16 1 Introduction 17 Somatic mutations accumulate throughout our lifetime, arising from external sources or from processes 18 intrinsic to the cell 1, 2 . Some sources generate characteristic patterns of mutations. For example, smoking 19
Each plot is constructed from VAF data from a single tumour sample. Each line is an activity trajectory that depicts inferred activities for a single signature (y-axis) as a function of decreasing CCF (x-axis). The thin lines are trajectories from each of 30 bootstrap runs. The bold line depicts the mean activities across bootstraps. The vertical lines indicate time points in the original dataset, and are placed at the average CCF of their 100 associated mutations. Changes in activity trajectories are not necessarily aligned with vertical bars because mean CCFs of time points change across bootstraps. Frequency of changepoints between two vertical bars is indicated by shade, the darker shades indicate higher density of changepoints. Subclonal boundaries found by PCAWG consensus clustering 24 are shown in red vertical lines. These boundaries are not used in trajectory calculation and are only shown for comparison. Histograms show the mutation counts per signature in fixed width intervals of CCF. (a) Breast cancer sample In clonal signatures remain constant with dominating signature 3 (associated with BRCA1 mutations). In the subclone activity to signature 3 decreases and is replaced by SNVs associated with APOBEC/AID (signatures 2 and 13). (b) Chronic lymphocytic leukemia sample Signature 9 (somatic hypermutation) dominates during clonal expansion and drops from 55% activity to almost zero in the subclone. Signature 5 compensates for this change.
first time point can contain more than 100 mutations. To determine a signature activity at this new time point, 155 TrackSig simply takes an average activity of all merged time points (those having CCF ≥ 1). 156 
5/36
Number of distinct subclones To compute the number of distinct subclones, we adjust the number of To compare the direction of the activity change, we divide signatures into those with: decreasing activity, 245 increasing activity, and no activity change (i.e., max change is less than 5%). The direction of maximum 246 change is consistent in 95.2% of all signatures across all simulations. 247 To compute number of false positives and false negatives, we count a true positive detection if at least 248 one of predicted changepoints occur with three time points of an actual one. A false negative is when no 249 predicted changepoints are within three time points of an actual change. This criteria is identical to the one 250 we use to evaluate whether a changepoint supports a subclonal boundary 24 . We deem a predicted changepoint 251 a false positive if it occurs more than three time points away from the closest actual changepoint.
252 Table 1 shows the percentage of simulations where we observe a certain number of false positives. On (see Appendix C.5). The signature activities for the neutral mutations were the same as those of the other 277 mutations associated with the clonal cluster.
278
Branching To assess TrackSig's accuracy when the timeline does not reflect the ordering of acquistion of 279 SNVs, we generated VAF data from a branched phylogeny. In branching simulation we generated VAF data 280 assuming a branching clonal tree with two subclones. We force the sum of subclonal CCFs to be less than 1, 281 otherwise the infinite sites assumption will be violated 1 . A later occurring subclone with a different signature 282 activity profile has a higher CCF than a subclone with a profile matching the clonal fraction. We sample 283 mutation VAFs and mutation types for the clusters similarly to the one-and two-cluster cases.
284
CNA gain We next assess TrackSig's accuracy for reconstructing activity changes when SNV VAFs are 285 affected by a CNA. We generated VAF data with a clonal CNA gain affecting 10% of the SNV VAFs. In 5% 286 of mutation the CNA gain is affecting the mutant allele and in 5% the CNA gain is affecting the reference 287 allele. This simulation is created similarly to branching with three clusters. The difference is that we modify 288 the probability of sampling a mutant allele to consider the mutant and reference copy numbers. (a) Simulated data was generated with two clusters and clonal neutral mutations at read depth 100. TrackSig incorrectly places a changepoint before a cluster of neutral mutations from the clonal lineage near the VAF detection limit. However, because the signature activities match those in the clonal cluster, this error could be detected and corrected in post-processing. (b) Simulated data was generated with two clusters at read depth 10. TrackSig correctly identifies one changepoint. Although the simulation contains two clusters, there is only a single mode of CCF, thus making CCF-cluster-based detection of subclones impossible. However, the histogram on top shows that there are differences in mutation type distributions between the left and right tails, permitting TrackSig to correctly identify a changepoint. Both figures use an expanded x-axis that shows the whole spread of estimated CCF, this is indicated with a change in the x-label descriptor.
activity and remain constant. On average 3.6% of overall activity is made up of low-activity signatures (with for each cancer type are available from a variety of sources 2, 36 .We highly recommend using either these sample-specific-sigs, first fits signature activities to the full set of mutation counts using an initial set of 388 signatures, and sets the active signatures to be those with activities greater than a threshold (by default, 5%) 389 in the initial fit. Then TrackSig computes activity trajectories only for the active signatures. In the following, 390 we evaluate sample-specific when the initial set is all-sigs, however, we suspect this approach will also work 391 well with cancer-type-specific as the initial set. We evaluate each strategy by comparing the active signatures 392 selected by TrackSig with those reported by PCAWG-Signature group on the PCAWG tumour set 36 .
393
For all-sigs, we used all 48 signatures and we found on average, 44.7% of overall activity assigned by 394 TrackSig is assigned to the active signatures selected by PCAWG-Signature group. Each incorrect signature 395 gets 1.3% of activity on average. In other words, the incorrect activity is widely distributed among the 396 signatures. Using cancer-type-specific-sigs improves the correspondence to 68.7% of the total activity on 397 average. This strategy reduces the initial set of potentially active signatures from 48 down to 12 on average 398 (ranging from 4 signatures in Lower Grade Glioma to 24 signatures in Liver Cancer). Here, we observe TrackSig is designed to be applied to VAF data on SNVs from a single sample, however, it can be applied to either sorted lists of point mutations derived from subclonal reconstruction algorithms, or CCFs from a 412 single cancer sample derived from methods which perform multi-sample reconstructions or subclonal CNA 413 reconstructions.
414
Changepoints often correspond to boundaries between subclones 24 . In our simulations we show that 415 TrackSig often better detects subclones than methods explicitly designed to find subclones, especially when 416 there is a mismatch between the assumed and actual VAF generation process. By reconstructing changes in 417 signature activities, TrackSig can potentially help identify DNA damage repair processes disrupted in the cell 418 and, in doing so, help inform treatment 11 . Previous approaches estimate signature activities for a group of mutations without considering their timing 421 (e.g. eMu 33 or deconstructSigs 13 ). Therefore, the attempts to compare activity changes across evolutionary 422 history have relied on pre-defined groups of mutations, such as those occurring before or after whole genome 423 duplications 7, 9, 29, 37 ; those classified as clonal or subclonal 1, 9 ; or those grouped in subclones via multi-region 424 sequencing [15] [16] [17] [18] [19] . As such, the accuracy of these methods relies on i) the accuracy in grouping mutations 425 based on VAF -which is low with data from a single bulk sample 21 ; and ii) the existence of a small number 426 of subclones or mutation groups within a sample, which is not true for neutrally evolving tumours 23, 25, 38 . 427 In contrast, TrackSig uses the distributions of mutation types to group mutations, this permits more 428 accurate reconstruction of signature activities than clustering mutations by VAF alone. Indeed, as our 429 simulations demonstrate, not only are the signature activities more accurately reconstructed, but in some 430 cases, TrackSig is a more sensitive detector of subclones. Furthermore, TrackSig makes fewer assumptions 431 about the underlying VAF distribution, so it can be readily applied to data from neutrally evolving tumour 432 populations 25, 38 . Our simulations further demonstrate that TrackSig's reconstructions are less sensitive to 433 model misspecification errors, such as violations of the infinite sites assumptions.
434
Clustering methods applied to VAFs from single bulk samples require high read depth for accuracy 21 .
435
Indeed, due to this challenge, previous approaches have used multi-region sequencing 15-19, 23, 38-41 . In 436 contrast, TrackSig can be deployed in a much larger range of settings. Separately, we report that TrackSig 437 can detect subclones that are missed by VAF clustering methods. 24
438
Another important innovation of TrackSig is the use of CCF as a surrogate for evolutionary timing. 439 Similar ideas have been used in human population genetics, where variant allele frequency to get relative 440 order of mutations along the ancestral lineage 42 . In population genetics, allele frequency is calculated across 441 individuals, while we calculate VAF across cell population within a single sample. In TrackSig we estimate 442 cancer cell fraction (CCF) and reconstructions of clonal CNAs. 
Sensitivity to misorderings of the SNVs

444
For ease of presentation, we have assumed that ordering SNVs by CCF recovers the order in which they accu-445 mulated in the genomes of ancestral cells. However, this assumption is not critical for correct reconstruction 446 of signature activity changes.
447
First, we have shown through bootstrap sampling and the clonal evolution simulations that errors in 448 the estimation of SNV CCFs due to sampling noise have a limited impact on TrackSig's ability to estimate 449 accurate activity trajectories. We have similarly shown that these activity trajectories are not impacted if a 450 small fraction (3%) of the SNVs violate the infinite sites assumption.
451
However, these trajectories can be impacted by incorrect ordering of a large numbers of SNVs. These can 452 occur in two ways. First, misordering can occur if a CNA changes the number of SNV allele's per cell. For 453 example, daughter cells can fail to inherit SNVs in their mother cells due to a loss of heterozygosity (LOH). difficulty. However, if a CNA reconstruction is not available, or it is inaccurate, the accuracy of the activity trajectories can suffer. As such, we recommend only using TrackSig when CNA reconstructions are available 458 and reliable.
459
Second, SNV ordering need not correspond to time of acquisition when a single sample contains SNVs 460 from subclones from different branches of the cancer phylogeny. In these circumstances, there is not a single 461 linear order for the activities, and furthermore late occurring subclones on a different branch can have higher 462 CCF than earlier ones occurring in the sample. This situation also occurs when the sample contains a large 463 number of neutrally evolving mutations from multiple subclonal lineages. Note that such circumstances 464 are rare in single biopsies 29 and that furthermore, a subclone can only be misordered if its CCF is less than 465 50% due to the Pigeonhole Principle 1 , so the ordering by CCFs in guaranteed to be correct up until 50% 466 CCF. However, even when these misorderings occurs, our simulations demonstrate that, with one exception,
467
TrackSig's activity reconstructions, and estimation of number of subclones, are largely unaffected.
468
Even in the rare circumstance that SNV misordering does occur, it may be possible to detect it, and 469 interpret the activity changes correctly. For example, if late occurring but misordered SNVs manifest a more 470 drastic change in signature activity, this misordering may be detectable by the presence of oscillations in the 471 activity trajectories. To address this issue, when assessing overall change in signature activity, we computed 472 the difference between the lowest and highest activities for each signature. This difference will be consistent 473 regardless of ordering. 475 In TrackSig, the number of mutation types is provided as a parameter and is not fixed to 96 types. Because of 476 this, it is straightforward to generalize TrackSig to reconstruct the activities of different mutation signatures 477 or different mutations, so long as these mutations can be approximately ordered by their evolutionary time 478 and each mutation can be classified into one of a fixed number of categories. In this paper, we ordered 479 SNVs by decreasing CCF. This same strategy could be naturally extended to indels for which the infinite 480 sites assumption is also valid. The infinite sites assumption should also be valid for structural variants (SVs) 481 associated with well-defined breakpoints, thus permitting TrackSig to be used to track activities to recently 482 defined SV signatures 37 . The CCFs of SVs can be estimated using the VAFs of split-reads mapping to their 483 breakpoints 43 . Because they cover larger genomic regions, infinite sites is less valid for CNAs, although it is 484 possible to approximately order clonal CNAs based on the inferred multiplicity of SNVs affected by them 9 .
Applicability to other mutation types and multi-region sequencing
485
TrackSig also requires a pre-defined set of mutation signatures, each of which is a probability distribution 486 over the mutation types. However, if these signatures are unavailable, they can be defined by non-negative 487 matrix factorization, or Latent Dirichlet Allocation 44 , if counts across mutation types are available from 488 multiple cancer samples.
489
TrackSig can be applied to VAFs from bulk sequencing data from multi-region sequencing or longitudinal 490 samples by simply running it on each sample separately. In preliminary experiments testing this approach we 491 found broad consistency in the active signature selected, and in the signature activities of the clonal mutations 492 in each sample. We observe with only 0.03% mean absolute activity difference (0.017 KL divergence) 496 The timelines reconstructed by TrackSig are computed with a fixed number of mutations in each bin. If 497 overall rate of generating mutations in tumour was constant, our timeline would correspond to the real time.
Accounting for changes in mutation rate
498
However, tumour mutation rate often accelerates throughout development 45, 46 . Although the changing rate 499 does not affect our analysis, the estimates of the pseudo-time might not be linearly related to real time.
500
Estimating changes in overall mutation rate is difficult. A possible way to correct for this is to adjust 501 the time line based on activities of signatures 1 and 5. Some report that signatures 1 and 5 operate as a 502 16/36 cell "clock" as the number of mutations contributed by these signatures is proportional to the age of the 503 individual 6 . Determining the association between our pseudo-time estimates and real time is left for further 504 investigation.
506
Our method TrackSig provides further insight how signature profile changes throughout tumour develop-507 ment. We show that through signatures analysis we can detect major events in tumour evolution, notably, 508 transitions to a new subclone. Mutational signatures provide a unique way to recover tumour evolution path, 509 track activities of mutational processes, adjust the treatment strategy and detect changes in therapy response. 
A mutation process is represented as a distribution over mutation types, known as a "mutation signature".
686
We will denote signature multinomials as K-dimensional probability vectors µ µ µ i , where i = {1..M} is an index 687 over signatures. Signatures are fixed and are not updated during the training.
688
We aim to estimate signature activities π π π -the proportion of mutations generated by each signature.
690
We will use the following notation: We represent mutation matrix X as a mixture of signature multinomials µ µ µ 1 1 1 , ..µ µ µ K K K with mixture coefficients π π π: 703 X ∼ Multinomial(N;
We denote z n to be the signature assignment of mutation n. The probabilities of mutation n to be assigned 704 to i-th signature are equal to the mixing coefficients:
The probability of a mutation n to be generated by signature i is given by:
Then log likelihood of the collection of mutations in a sample:
To estimate the activities, we fit mixing coefficients π π π in each bin using Expectation-Maximization (EM) 708 algorithm 32 . The EM algorithm iterates between updating a posterior distribution over z n and updating an 709 estimate of the mixing coefficients π π π 710 We start with initializing EM algorithm with uniform mixing coefficients:
Then, we repeat the following E-step and M-step until the algorithm converges.
712
In E-step, at the t-th iteration, the posterior probabilities of mutation assignments to signatures are 713 estimated as such:
In M-step we update the estimates of the mixing coefficients:
The algorithm has converged when the value of π is updated by less than 0.001 between iterations.
716
The resulting mixture coefficients as the activities of the mutational signatures. We show the activities as 717 percentage for the convenience of interpretation. We adapt Pruned Linear Exact Time (PELT) 34 algorithm to detect change points in activity trajectories given 721 cost function (likelihood) and BIC penalty. PELT is based on dynamic programming and uses heuristics to 722 prune the set potential changepoints, thus reducing the computational time.
723
In this section, we will use the following notation: As described in 2.1.2, we separate mutations into bins 100 mutations, each of which represents one time 729 point. Our input is the set of mutation counts across 96 types for each time point: y 1:T = (y 1 , . . . , y T ). We aim 730 to find P changepoints, or in other words, P + 1 segments. We denote τ 1:P = (τ 1 , . . . , τ P ) to be the boundaries 731 for our segments, meaning each segment will contain the data points y τ i−1 ..y τ i .
732
Given a set of changepoints we can compute the likelihood of the data the following way. We fit mutational 733 signatures within each segment (treating all mutations within each segment as one bin) and compute the 734 likelihoodL (y τ i−1 ..y τ i ) as described in A. The total likelihood is the sum of likelihoods in each segment:
We aim to minimize the Bayesian Information Criterion (BIC):
where k is the number of parameters in our model and T is the number of time points. In our case 736 k = (P + 1) · (M − 1) as we fit (M − 1) signature activities in (P + 1) segments (recall that signature activities 737 sum to 1). 738 We adapt PELT objective to minimize the BIC criterion. PELT aims to minimize sum of cost functions at 739 each time point, while using a penalty β for each placed changepoint
Intuitively, we are trying to select changepoints which result in the lowest cost (or highest likelihood) 741 while reducing the penalty associated with adding changepoints. We set the parameters as follows to make 742 the PELT equivalent to BIC:
TrackSig-PELT algorithm finds the changepoints as follows. The algorithm starts with finding a partial 744 solution in a subset of the timeline and then increases the search space until changepoints are located over the PELT provides an improvement in runtime by pruning certain changepoints from consideration. We prune
The cost of placing the last changepoint prior to T at t will always be higher than cost of placing the last 756 changepoint prior to T at s. Given this result, we can eliminate t as a potential changepoint for all iterations 757 of the dynamic programming algorithm as it will never be optimal going forwards. 
Append τ to cp 6:
In branching simulations, we expect to see the signature activity for A1 signature decreases at the transition to the second cluster and increases again at the transition to the third subclone. If such step-like 804 behavior of is observed in real data, we consider this a sign of branching. Note that if we reversed the order 805 of the branched clusters and assigned the same signature activities to the first and second clusters, it woudn't 806 be possible to distinguish between these two clusters since TrackSig can only find changepoints based on 807 signature change.
808
To show the effect of branching on signature trajectories, we assign similar activities to the first (clonal) 809 and third cluster (with the smallest CCF), but introduce a signature change in the second (middle) cluster.
810
To do this, we sample signature activity for A1 from Uniform([0.4,0.7]), calculate the exposures for other 811 signatures and assign the same activities to the first and last cluster. For the middle cluster, we sample activity 812 for A1 signature from Uniform([0.2, 0.4]). As before, we sample activity of time-related signature S1 from CNA gain simulations are based on the branching simulations described above and has three clusters: clonal 817 and two subclones. 818 We introduce a CNA gain for 10% of mutations in the clonal cluster: 5% of mutations have CNA gain on 819 the mutant allele and 5% have CNA gain on reference allele. Thus, 10% of mutations get total copy number 820 3 and mutant copy number of 2 and 1 respectively. We assume that these copy number changes are inherited 821 by both subclones. To simulate the CNA change, we adjust the mutant_CN and total_CN parameter in 822 Algorithm 3 for 10% of mutations in each cluster. We provide total copy number a input to both TrackSig 823 and SciClone. 825 To simulate the violation of infinite site assumption (ISA), we create four clusters. The first three clusters are 826 created the same way as in the branching simulation. The forth cluster simulates mutations that occurred in 827 both clusters independently, thus violating ISA. The CCF of the forth cluster is the sum of CCFs of the two 828 subclonal clusters. We assign 3% of all mutation to the forth cluster. As expected, the presence of mutations 829 that violate ISA don't affect signature activity trajectories.
824
C.4 Violation of infinite site assumption
830
C.5 Neutral Evolution Mutations
831
To make our simulations more realistic, we add mutations which emerged due to neutral evolution. We follow 832 Williams et al. 25 for generating mutations from neutral evolution. First, we establish the number of neutral 833 mutations to be generated. Then we sample those mutations according to the power-law distribution 1
where f is variant allele frequency. Both steps are described in more detail below.
835
The number of neutral mutations is computed as follows:
where f c is the variant allele frequency (VAF) of the cluster, f min is a minimal VAF in consideration and 837 µ e is effective mutation rate. For clonal cluster, f c = 0.5. We only consider mutations with 3 or more mutant 838 reads. Therefore, we set f min = 3 d , where d is the mean depth of the simulation. We use µ e = 16 27 . 
To sample from this distribution, we take samples from uniform distribution and then use inverse cumulative distribution function (I-CDF) to transform them into samples from power-law distribution. Inverse
where f is our target allele frequency (i.e. sample from the power-law) and u is a sample from uniform 845 distribution.
846
After discussion with our colleagues from population genetics, we decided to generate neutral mutations 847 only from a clonal cluster. Figure 4b shows the example of generated simulation at depth 10.
852
D SciClone+DeconstructSigs baseline 853
To showcase the potential of our method, we compared TrackSig to SciClone+DeconstructSigs pipeline 854 which is commonly used to infer signature activities. Algorithm 2 Simulation algorithm for two clusters Input: mean mutation depth d, number of mutations N 1: mutant_CN = 1 2: total_CN = 2 3: Sample CCFs for each cluster: 4: cc f 1 = 1. CCF of the clonal cluster is set to 1. 5: cc f 2 ∼ Uni f orm(0.2, 0.6) 6: Sample number of mutations per cluster: 7: N c2 = cc f 2 * N 8: N c1 = N − N c2 9: Sample two active signatures A1, A2 for the current tumour sample, excluding S1 and S5 10: Set active signatures to (S1, S5, A1, A2) 11: for each cluster i in 1..2 do for each signature s in active signatures (S1, S5, A1, A2) do Convert trinucleotide counts into a a vector of mutation types of length N c i
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Algorithm 3 Simulation algorithm for branching with three clusters Input: mean mutation depth d, number of mutations N 1: mutant_CN = 1 2: total_CN = 2 3: Sample CCFs for each cluster: 4: cc f 1 = 1. CCF of the clonal cluster is set to 1. 5: cc f 3 ∼ Uni f orm(0.2, 0.35) 6: cc f 2 ∼ Uni f orm(cc f 2 + 0.15; = 1 − cc f 2 − 0.15) CCF of the middle cluster is set to be at least 0.15 CCF apart from third cluster. Sum of CCFs from second and third clusters should not exceed 1 because they are branched. 7: Sample number of mutations per cluster: 8: N c3 = cc f 3 * N 9: N c2 = cc f 2 * N 10: N c1 = N − N c2 − N c3 11: Sample two active signatures A1, A2 for the current tumour sample, excluding S1 and S5 12: Set active signatures to (S1, S5, A1, A2) 13: for each cluster i in 1..3 do for each signature s in active signatures (S1, S5, A1, A2) do Convert trinucleotide counts into a a vector of mutation types of length N c i 29/36 Table 2 . Simulation results. Predicted changepoints versus changepoints in the ground truth. Each cell shows the percentage of simulations which have certain number of estimated changepoints (normalized within a column). Note that due to smoothing, there might be several predicted changepoints that correspond to the same changepoint in the ground truth. In this case, predicted changepoints have to be located no more than 3 time points away from the ground truth. Figure F.9 . Multi-region cases. Each subplot shows signature trajectories for different samples from the same tumour. Signature trajectories shown are the mean of 30 bootstrap trajectories and therefore are not piece-wise constant. We report mean activity difference and KL divergence between the activities in the clonal cluster only. We compare clonal activities across the groups of samples with the same set of active signatures. Tumour DO51954: Group 1 with active signatures "SBS1 SBS5 SBS40": mean activity diff 0.0573, KL divergence 0.05. Group 2 with signatures "SBS1 SBS5 SBS18 SBS40": mean activity diff 0.036, KL divergence 0.018 Tumour DO51958: Group 1 with active signatures "SBS1 SBS5 SBS18 SBS40": mean activity diff 0.014, KL divergence 0.002. Group 2 with signatures "SBS1 SBS5 SBS18 SBS40 SBS2+13": mean activity diff 0.008, KL divergence 0.001. Tumour DO51965: Group with active signatures "SBS1 SBS3 SBS18 SBS40": mean activity diff 0.042, KL divergence 0.028. Tumour DO51953: Group with active signatures "SBS1 SBS5 SBS40": mean activity diff 0.031, KL divergence 0.005. Tumour DO51959: Group with active signatures "SBS1 SBS5 SBS18 SBS41": mean activity diff 0.011 , KL divergence 0.0014. Tumour DO51962: Group with signatures "SBS1 SBS3 SBS5 SBS8 SBS40": mean activity diff 0.037, KL divergence 0.031.
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